Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Wirshing

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|October 5, 2001
Adverse effects of atypical antipsychoticsD A Wirshing
Biological Psychiatry|August 31, 2001
Risperidone-associated new-onset diabetesD A Wirshing, J M Pierre, J Eyeler, et al.
The American Journal of Psychiatry|November 13, 1998
Informed consent: assessment of comprehensionD A Wirshing, W C Wirshing, S R Marder, et al.
Biological Psychiatry|November 3, 1998
Novel antipsychotics and new onset diabetesD A Wirshing, B J Spellberg, S M Erhart, et al.
Schizophrenia Research|December 1, 2001
Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoateS R Marder, M Aravagiri, W C Wirshing, et al.
Journal of Clinical Psychopharmacology|August 5, 1998
Olanzapine-induced reversible priaprism: a case reportJ M Deirmenjian, S M Erhart, D A Wirshing, et al.
Biological Psychiatry|June 22, 1999
Choreoathetoid movements in cocaine dependenceG Bartzokis, M Beckson, D A Wirshing, et al.
The American Journal of Psychiatry|September 15, 1999
Risperidone in treatment-refractory schizophreniaD A Wirshing, B D Marshall, M F Green, et al.
Biological Psychiatry|October 20, 1998
Tardive dyskinesia and serum iron indicesD A Wirshing, G Bartzokis, J M Pierre, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Novel antipsychotics: comparison of weight gain liabilitiesD A Wirshing, W C Wirshing, L Kysar, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|October 5, 2001
Adverse effects of atypical antipsychoticsD A Wirshing
Biological Psychiatry|August 31, 2001
Risperidone-associated new-onset diabetesD A Wirshing, J M Pierre, J Eyeler, et al.
The American Journal of Psychiatry|November 13, 1998
Informed consent: assessment of comprehensionD A Wirshing, W C Wirshing, S R Marder, et al.
Biological Psychiatry|November 3, 1998
Novel antipsychotics and new onset diabetesD A Wirshing, B J Spellberg, S M Erhart, et al.
Schizophrenia Research|December 1, 2001
Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoateS R Marder, M Aravagiri, W C Wirshing, et al.
Journal of Clinical Psychopharmacology|August 5, 1998
Olanzapine-induced reversible priaprism: a case reportJ M Deirmenjian, S M Erhart, D A Wirshing, et al.
Biological Psychiatry|June 22, 1999
Choreoathetoid movements in cocaine dependenceG Bartzokis, M Beckson, D A Wirshing, et al.
The American Journal of Psychiatry|September 15, 1999
Risperidone in treatment-refractory schizophreniaD A Wirshing, B D Marshall, M F Green, et al.
Biological Psychiatry|October 20, 1998
Tardive dyskinesia and serum iron indicesD A Wirshing, G Bartzokis, J M Pierre, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Novel antipsychotics: comparison of weight gain liabilitiesD A Wirshing, W C Wirshing, L Kysar, et al.
Pageof 2